Literature DB >> 17389442

Ovarian cancer risk in relation to medical visits, pelvic examinations and type of health care provider.

Haim A Abenhaim1, Linda Titus-Ernstoff, Daniel W Cramer.   

Abstract

BACKGROUND: Whether the current recommendations for ovarian cancer prevention and screening (annual history and physical examination) are effective has not been evaluated. We examined the relation between health care use and the risk of ovarian cancer.
METHODS: Using a case-control study design, we recorded the frequency of medical visits and pelvic examinations and the type of health care provider visited during a 5-year period from interviews with women with and without ovarian cancer between between July 1998 and July 2003. We used multivariable logistic regression analysis to calculate the adjusted odds ratio of ovarian cancer associated with the frequency of medical visits and pelvic examinations and the type of health care provider. In addition, we stratified cases and controls by menopausal status and cancer histologic subtype and grade.
RESULTS: A total of 668 cases and 721 age-matched controls agreed to participate in the study. We observed an increased risk of ovarian cancer among women who, during the 5-year study period, did not have a medical visit (odds ratio [OR] 2.8, 95% confidence interval [CI] 1.5-5.0) or pelvic examination (OR 3.9, 95% CI 2.2-6.9) or who had no regular health care provider (OR 2.7, 95% CI 1.3-5.7). This increase in risk was most pronounced among women who were postmenopausal (no medical visit, OR 7.7, 95% CI 2.6-23.0; no pelvic examination, OR 3.3, 95% CI 1.7-6.0; no health care provider, OR 12.5, 95% CI 2.7-57.5).
INTERPRETATION: Although the exact mechanism underlying the association between medical visits, pelvic examinations and type of health care provider and ovarian cancer is unknown, women should be encouraged to maintain regular medical care.

Entities:  

Mesh:

Year:  2007        PMID: 17389442      PMCID: PMC1828193          DOI: 10.1503/cmaj.060697

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  31 in total

1.  Dietary antioxidants, supplements, and risk of epithelial ovarian cancer.

Authors:  A T Fleischauer; S H Olson; L Mignone; N Simonsen; T A Caputo; S Harlap
Journal:  Nutr Cancer       Date:  2001       Impact factor: 2.900

2.  Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography.

Authors:  S Sato; Y Yokoyama; T Sakamoto; M Futagami; Y Saito
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

3.  The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.

Authors:  J R van Nagell; P D DePriest; M B Reedy; H H Gallion; F R Ueland; E J Pavlik; R J Kryscio
Journal:  Gynecol Oncol       Date:  2000-06       Impact factor: 5.482

4.  Beyond ovulation: oral contraceptives and epithelial ovarian cancer.

Authors:  V Siskind; A Green; C Bain; D Purdie
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

5.  Prospective study of talc use and ovarian cancer.

Authors:  D M Gertig; D J Hunter; D W Cramer; G A Colditz; F E Speizer; W C Willett; S E Hankinson
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

6.  Carotenoids, antioxidants and ovarian cancer risk in pre- and postmenopausal women.

Authors:  D W Cramer; H Kuper; B L Harlow; L Titus-Ernstoff
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

7.  Cigarette smoking and epithelial ovarian cancer by histologic type.

Authors:  P A Marchbanks; H Wilson; E Bastos; D W Cramer; J M Schildkraut; H B Peterson
Journal:  Obstet Gynecol       Date:  2000-02       Impact factor: 7.661

Review 8.  HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.

Authors:  W W L Wong; J Dimitroulakos; M D Minden; L Z Penn
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

9.  Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?

Authors:  Hannah Kuper; Daniel W Cramer; Linda Titus-Ernstoff
Journal:  Cancer Causes Control       Date:  2002-06       Impact factor: 2.506

10.  Long-term effects of oral contraceptives on ovarian cancer risk.

Authors:  Cristina Bosetti; Eva Negri; Dimitrios Trichopoulos; Silvia Franceschi; Valerie Beral; Anastasia Tzonou; Fabio Parazzini; Stefano Greggi; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2002-11-20       Impact factor: 7.396

View more
  4 in total

1.  Health care use and risk of ovarian cancer: is there a link?

Authors:  Michael Fung-Kee-Fung; Melissa Brouwers; Thomas K Oliver; Barry Rosen
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

Review 2.  A terrible beauty: a physician's story of ovarian cancer.

Authors:  Linda J Spano
Journal:  Can Fam Physician       Date:  2007-06       Impact factor: 3.275

3.  Symptom interpretation and health care seeking in ovarian cancer.

Authors:  Lene Seibaek; Lone K Petersen; Jan Blaakaer; Lise Hounsgaard
Journal:  BMC Womens Health       Date:  2011-06-23       Impact factor: 2.809

4.  Associations between provider designation and female-specific cancer screening in women Veterans.

Authors:  Bevanne Bean-Mayberry; Lori Bastian; Mark Trentalange; Terrence E Murphy; Melissa Skanderson; Heather Allore; Evelyn Reyes-Harvey; Natalya C Maisel; Vera Gaetano; Steven Wright; Sally Haskell; Cynthia Brandt
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.